SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Stand Up for APA, a nonprofit working to ensure that women of every background, race, ethnicity, and socioeconomic status in the United States receive access ...

Today, the U.S. Food and Drug Administration is warning the public of the risk of false results, inappropriate use and inappropriate interpretation of results with non-invasive prenatal screening ...

DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has ...

Two of the world's largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to ...

A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum ...

Alessandro Marcon works at the University of Alberta's Health Law Institute, which has received funding related to this project from Genome Canada, Genome Alberta, and CIHR. Vardit Ravitsky receives ...

The "Global Non-Invasive Prenatal Testing Market Report by Application Component End User Countries and Company Analysis, 2024-2032" report has been added to ResearchAndMarkets.com's offering. Global ...

The U.S. Food and Drug Administration is warning women about a screening commonly performed during pregnancy. Non-invasive prenatal screening tests carry a risk of false results, the FDA said in a ...

Pregnant women can have prenatal testing performed during their pregnancies to determine whether or not their baby could have certain disorders. Two types of tests are chorionic villus sampling (CVS) ...

With the PrenaTest®, Europe’s first non-invasive prenatal test for the determination of the most common chromosomal disorders in unborn children, launched in 2012, LifeCodexx has been changing ...